Bridgepoint Development Capital, an alternative asset manager, agreed to acquire Baird Capital-backed Prescient Healthcare Group, a UK healthcare provider. Financial terms were not disclosed. “I’m excited by the collaborative approach and hunger for excellence that Bridgepoint will bring to the boardroom and much look forward to our partnership as we continue to invest in our passion for helping our amazing clients develop and commercialize innovative treatments that bring such hope and relief to patients globally,” Jamie Denison-Pender, Prescient CEO.